SCHEMBL9911194

SCHEMBL9911194

CC[C@H]1OC(O)(c2ccc[nH]2)[C@](C)(OCc2ccccc2)[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13531952 0.80 BCHE (0.33) —
SCHEMBL14039001 0.71 — —
SCHEMBL12393305 0.70 KDM4E (0.32) —
SCHEMBL14039037 0.70 TNK2 (0.35) —
SCHEMBL12243145 0.70 TNK2 (0.35) —
SCHEMBL14038961 0.69 KDM4E (0.30) —
SCHEMBL9911193 0.68 — —
SCHEMBL9911195 0.65 IDO1 (0.33) —
SCHEMBL12243142 0.62 ALDH1A1 (0.37) —
SCHEMBL27740112 0.61 TSHR (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142617-A1 ANTIVIRAL THERAPEUTIC AGENTS BIOCRYST PHARMACEUTICALS, INC. (US) 2012-06-07 — — US disclosed
Send feedback